Human C-Peptide Trifluoroacetate

Supplier: Bachem
4009494.1000 4009494.0500
H-2470.1000BAEA 546.59 USD
H-2470.1000BA H-2470.0500BA
Human C-Peptide Trifluoroacetate
Proteins and Peptides
Synthesized prosequences from insulin.

The measurement of the C-peptide under standardized conditions provides a sensitive, well accepted, and clinically validated assessment of β-cell function. The C-peptide measurement is the most suitable primary outcome for clinical trials of therapies aimed at preserving or improving endogenous insulin secretion in type 1 diabetes patients. C-peptide also shows hormonal activity. Clinical studies demonstrated that C-peptide administration in type 1 diabetes patients, who lack the peptide, alleviates the diabetes-induced renal and nerve dysfunctions.
Order Now

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR